Becton Dickinson and Co (BDX) Shares Sold by Quadrant Capital Management LLC

Quadrant Capital Management LLC decreased its position in Becton Dickinson and Co (NYSE:BDX) by 9.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 17,648 shares of the medical instruments supplier’s stock after selling 1,792 shares during the quarter. Becton Dickinson and comprises 2.7% of Quadrant Capital Management LLC’s investment portfolio, making the stock its 8th largest holding. Quadrant Capital Management LLC’s holdings in Becton Dickinson and were worth $3,778,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Koch Industries Inc. boosted its position in Becton Dickinson and by 45,268.7% during the second quarter. Koch Industries Inc. now owns 1,398,264 shares of the medical instruments supplier’s stock worth $1,391,000 after purchasing an additional 1,395,182 shares during the period. Vanguard Group Inc. boosted its position in Becton Dickinson and by 8.5% during the second quarter. Vanguard Group Inc. now owns 17,255,948 shares of the medical instruments supplier’s stock worth $3,366,809,000 after purchasing an additional 1,353,780 shares during the period. Winslow Capital Management LLC bought a new stake in Becton Dickinson and during the second quarter worth approximately $225,164,000. Janus Henderson Group PLC boosted its position in Becton Dickinson and by 1,265.9% during the second quarter. Janus Henderson Group PLC now owns 1,210,837 shares of the medical instruments supplier’s stock worth $236,245,000 after purchasing an additional 1,122,191 shares during the period. Finally, Parametric Portfolio Associates LLC boosted its position in Becton Dickinson and by 216.2% during the second quarter. Parametric Portfolio Associates LLC now owns 1,320,259 shares of the medical instruments supplier’s stock worth $257,596,000 after purchasing an additional 902,761 shares during the period. 75.68% of the stock is owned by institutional investors and hedge funds.

Shares of Becton Dickinson and Co (NYSE:BDX) opened at $237.11 on Monday. Becton Dickinson and Co has a 12-month low of $175.66 and a 12-month high of $248.39. The company has a debt-to-equity ratio of 1.44, a current ratio of 5.58 and a quick ratio of 5.03. The firm has a market capitalization of $63,169.73, a P/E ratio of 50.99, a PEG ratio of 1.69 and a beta of 1.12.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Friday, March 9th will be given a $0.75 dividend. The ex-dividend date is Thursday, March 8th. This represents a $3.00 annualized dividend and a dividend yield of 1.27%. Becton Dickinson and’s dividend payout ratio is 64.52%.

A number of brokerages have issued reports on BDX. Bank of America reaffirmed a “buy” rating and set a $260.00 target price on shares of Becton Dickinson and in a research report on Friday, January 19th. Zacks Investment Research raised Becton Dickinson and from a “hold” rating to a “buy” rating and set a $259.00 target price for the company in a research report on Friday, January 19th. Stifel Nicolaus reaffirmed a “buy” rating and set a $245.00 target price on shares of Becton Dickinson and in a research report on Friday, November 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $230.00 target price (up previously from $210.00) on shares of Becton Dickinson and in a research report on Friday, November 3rd. Finally, Morgan Stanley upped their target price on Becton Dickinson and from $205.00 to $245.00 and gave the stock an “equal weight” rating in a research report on Friday, November 3rd. Four equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. Becton Dickinson and has an average rating of “Buy” and an average target price of $233.80.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Stock Observer and is the sole property of of Stock Observer. If you are reading this article on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The correct version of this article can be accessed at https://www.thestockobserver.com/2018/02/05/becton-dickinson-and-co-bdx-shares-sold-by-quadrant-capital-management-llc.html.

About Becton Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply